| Aβ | amyloid β |
| AD | Alzheimer’s disease |
| ALS | autophagic-lysosomal system |
| BBB | Blood-brain barrier |
| CAZy | Carbohydrate Active Enzymes |
| Cer | ceramide |
| CNS | central nervous system |
| EGFR | epidermal growth factor receptor |
| ER | endoplasmic reticulum |
| ERT | enzyme replacement therapy |
| Fuc | fucose |
| Gal | galactose |
| GalNAc | N-acetylgalactosamine |
| GD | Gaucher disease |
| GDNF | glial derived neurotropic factor |
| GH | glycosyl hydrolase |
| Glc | glucose |
| GlcCer | glucosylβ-ceramide |
| GlcNAc | N-acetylglucosamine |
| GLTP | Glycolipid transfer protein |
| GPI | glycosylphosphatidylinositol |
| GSL | glycosphingolipid |
| GT | glycosyltransferase |
| HPLC | high pressure liquid chromatography |
| HPAEC | high performance anion exchange chromatography |
| LacCer | lactosyl-ceramide |
| LC | liquid chromatography |
| LMP | lysosomal membrane permeability |
| LRP | laminin receptor protein |
| LSD | lysosomal storage disease |
| Lyso-GSL | GSL lacking the fatty acid moiety |
| Man-6-P | mannose-6-phosphate |
| MS | mass spectrometry |
| Neu5Ac | 5-N-acetylneuraminic acid |
| Neu5Gc | 5-N-glycolylneuraminic acid |
| NMR | nuclear magnetic resonance |
| PD | Parkinson’s disease |
| PPCA | Cathepsin A |
| SAP | saposin |
| SD | Sandhoff disease |
| SNCA | α-synuclein |
| TNF | tumor necrosis factor |
| TSD | Tay–Sachs disease |
| UPS | ubiquitin-proteasome system |